Higuchi Satoshi, Ota Hideki, Yaoita Nobuhiro, Kamada Hiroki, Takagi Hidenobu, Satoh Taijyu, Yasuda Satoshi, Takase Kei
Department of Diagnostic Radiology, Tohoku University Hospital, Sendai, Miyagi, Japan.
Department of Diagnostic Radiology, Tohoku University Hospital, Sendai, Miyagi, Japan.
J Cardiol. 2023 Mar;81(3):297-306. doi: 10.1016/j.jjcc.2022.03.001. Epub 2022 Apr 28.
Chronic thromboembolic pulmonary hypertension (CTEPH), classified as group 4 pulmonary hypertension (PH), is caused by stenosis and obstruction of the pulmonary arteries by organized thrombi that are incompletely resolved after acute pulmonary embolism. The prognosis of patients with CTEPH is poor if untreated; however, in expert centers with multidisciplinary teams, a treatment strategy for CTEPH has been established, dramatically improving its prognosis. CTEPH is currently not a fatal disease and is the only curable form of PH. Despite these advances and the establishment of treatment approaches, early diagnosis is still challenging, especially for non-experts, for several reasons. One of the reasons for this is insufficient knowledge of the various diagnostic imaging modalities, which are essential in the clinical practice of CTEPH. Imaging modalities should detect the following pathological findings: lung perfusion defects, thromboembolic lesions in pulmonary arteries, and right ventricular remodeling and dysfunction. Perfusion lung scintigraphy and catheter angiography have long been considered gold standards for the detection of perfusion defects and assessment of vascular lesions, respectively. However, advances in imaging technology of computed tomography and magnetic resonance imaging have enabled the non-invasive detection of these abnormal findings in a single examination. Cardiac magnetic resonance (CMR) is the gold standard for evaluating the morphology and function of the right heart; however, state-of-the-art techniques in CMR allow the assessment of cardiac tissue characterization and hemodynamics in the pulmonary arteries. Comprehensive knowledge of the role of imaging in CTEPH enables appropriate use of imaging modalities and accurate image interpretation, resulting in early diagnosis, determination of treatment strategies, and appropriate evaluation of treatment efficacy. This review summarizes the current roles of imaging in the clinical practice for CTEPH, demonstrating the characteristic findings observed in each modality.
慢性血栓栓塞性肺动脉高压(CTEPH)被归类为第4组肺动脉高压(PH),由急性肺栓塞后未完全溶解的机化血栓导致肺动脉狭窄和阻塞引起。未经治疗的CTEPH患者预后较差;然而,在拥有多学科团队的专家中心,已确立了CTEPH的治疗策略,显著改善了其预后。CTEPH目前并非致命疾病,是唯一可治愈的PH类型。尽管取得了这些进展并确立了治疗方法,但早期诊断仍具有挑战性,尤其是对于非专家而言,原因有几个。其中一个原因是对各种诊断成像方式的了解不足,而这些方式在CTEPH的临床实践中至关重要。成像方式应检测以下病理表现:肺灌注缺损、肺动脉内的血栓栓塞性病变以及右心室重塑和功能障碍。长期以来,肺灌注闪烁显像和导管血管造影分别被视为检测灌注缺损和评估血管病变的金标准。然而,计算机断层扫描和磁共振成像技术的进步使得在一次检查中就能无创检测到这些异常表现。心脏磁共振(CMR)是评估右心形态和功能的金标准;然而,CMR的先进技术可用于评估心脏组织特征和肺动脉血流动力学。全面了解成像在CTEPH中的作用有助于合理使用成像方式并准确解读图像,从而实现早期诊断、确定治疗策略以及恰当评估治疗效果。本综述总结了成像在CTEPH临床实践中的当前作用,展示了每种成像方式所观察到的特征性表现。